← FDA Drug Approvals (Drugs@FDA)

AXITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2025-10-07

Drug application

FDA Application #

ANDA219705

Application type

Abbreviated New Drug Application (Generic)

Brand name

AXITINIB

Generic name

Axitinib

Active ingredients

AXITINIB

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

SANDOZ INC

First approval

2025-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown